bpc-157 oral capsules dosage protocol 500mcg Dosing (Common Protocols), πΉ / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or ipamorelin typical dosage protocol cjc
Description
References 15037862 Ditunno JF, Little JW, Tessler A, Burns AS

By supporting barrier integrity and reducing inflammation, these peptides may decrease autoimmune triggers originating in the gut
No clinic

By stimulating blood vessel growth, the peptide ensures that damaged tissues receive an adequate supply of oxygen and nutrients, while also facilitating the removal of metabolic waste

Mild injection-site reactions (redness, discomfort) can occur

Herniated discs treated with BPC-157 showed reduced compression on nerves and faster resolution of neurological symptoms compared to control groups
